Clinical data | |
---|---|
Trade names | Flumarin |
AHFS/ Drugs.com | International Drug Names |
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
CompTox Dashboard ( EPA) | |
Chemical and physical data | |
Formula | C15H18F2N6O7S2 |
Molar mass | 496.46 g·mol−1 |
3D model ( JSmol) | |
Melting point | 82.5 to 87.5 °C (180.5 to 189.5 °F) |
| |
| |
(what is this?) (verify) |
Flomoxef is an oxacephem antibiotic that was developed by Shionogi.
It has been classified either as a second-generation [1] or fourth-generation cephalosporin. [2]
It was patented in 1982 and approved for medical use in 1988 under the trade name Flumarin. [3]
Clinical data | |
---|---|
Trade names | Flumarin |
AHFS/ Drugs.com | International Drug Names |
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
CompTox Dashboard ( EPA) | |
Chemical and physical data | |
Formula | C15H18F2N6O7S2 |
Molar mass | 496.46 g·mol−1 |
3D model ( JSmol) | |
Melting point | 82.5 to 87.5 °C (180.5 to 189.5 °F) |
| |
| |
(what is this?) (verify) |
Flomoxef is an oxacephem antibiotic that was developed by Shionogi.
It has been classified either as a second-generation [1] or fourth-generation cephalosporin. [2]
It was patented in 1982 and approved for medical use in 1988 under the trade name Flumarin. [3]